Smith B - Search Results

1

High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.

Cooper C, Klein M, Walmsley S, Haase D, MacKinnon-Cameron D, Marty K, Li Y, Smith B, Halperin S, Law B, Scheifele D; Phac Cihr Influenza Research Network. Cooper C, et al. Among authors: smith b. HIV Clin Trials. 2012 Jan-Feb;13(1):23-32. doi: 10.1310/hct1301-023. HIV Clin Trials. 2012. PMID: 22306585 Clinical Trial.

2

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. Halperin SA, et al. Among authors: smith b. Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6. Vaccine. 2000. PMID: 10618527 Clinical Trial.

3

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Scheifele D, Mills E, Hasselback P, Pim C, Meekison W, Parker R, Lavigne P, Barreto L. Halperin SA, et al. Among authors: smith b. Pediatr Infect Dis J. 2000 Apr;19(4):276-83. doi: 10.1097/00006454-200004000-00003. Pediatr Infect Dis J. 2000. PMID: 10783014 Clinical Trial.

4

Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.

Halperin SA, McGrath P, Smith B, Houston T. Halperin SA, et al. Among authors: smith b. J Pediatr. 2000 Jun;136(6):789-94. J Pediatr. 2000. PMID: 10839878 Clinical Trial.

5

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

Halperin SA, Smith B, Mabrouk T, Germain M, Trépanier P, Hassell T, Treanor J, Gauthier R, Mills EL. Halperin SA, et al. Among authors: smith b. Vaccine. 2002 Jan 15;20(7-8):1240-7. doi: 10.1016/s0264-410x(01)00428-5. Vaccine. 2002. PMID: 11803087 Clinical Trial.

6

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age.

Halperin BA, Halperin SA, McGrath P, Smith B, Houston T. Halperin BA, et al. Among authors: smith b. Pediatr Infect Dis J. 2002 May;21(5):399-405. doi: 10.1097/00006454-200205000-00010. Pediatr Infect Dis J. 2002. PMID: 12150176 Clinical Trial.

7

Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.

Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, Smith B, MacDonald N. Halperin SA, et al. Among authors: smith b. Clin Invest Med. 2002 Dec;25(6):243-51. Clin Invest Med. 2002. PMID: 12516995 Clinical Trial.

8

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Among authors: smith b. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

9

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

Halperin SA, Van Nest G, Smith B, Abtahi S, Whiley H, Eiden JJ. Halperin SA, et al. Among authors: smith b. Vaccine. 2003 Jun 2;21(19-20):2461-7. doi: 10.1016/s0264-410x(03)00045-8. Vaccine. 2003. PMID: 12744879 Clinical Trial.

10

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.

Halperin SA, Smith B, Nolan C, Shay J, Kralovec J. Halperin SA, et al. Among authors: smith b. CMAJ. 2003 Jul 22;169(2):111-7. CMAJ. 2003. PMID: 12874157 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,347 results

Search Page

Filters